Jose Manuel Betancourt, MD | |
Hc 06 Box 14280, Hatillo, PR 00659-9721 | |
(787) 408-7169 | |
Not Available |
Full Name | Jose Manuel Betancourt |
---|---|
Gender | Male |
Speciality | Nephrology |
Experience | 15 Years |
Location | Hc 06 Box 14280, Hatillo, Puerto Rico |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1558676783 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RN0300X | Internal Medicine - Nephrology | 18604 (Puerto Rico) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Doctors' Center Hospital, Inc | Manati, PR | Hospital |
Manati Medical Center Dr Otero Lopez | Manati, PR | Hospital |
Mailing Address | Practice Location Address |
---|---|
Jose Manuel Betancourt, MD Hc 06 Box 14280, Hatillo, PR 00659-9721 Ph: (787) 408-7169 | Jose Manuel Betancourt, MD Hc 06 Box 14280, Hatillo, PR 00659-9721 Ph: (787) 408-7169 |
News Archive
Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, today announced that it has granted Novartis an option to obtain an exclusive worldwide license to develop and commercialize its p53 temporary inhibitor siRNA drug QPI-1002, currently the subject of a Phase II clinical trial.
Adimab, Inc., a world leader in human antibody discovery, today announced the closing of a Series D financing led by Google Ventures with participation by previous investors Polaris Ventures, SV Life Sciences, OrbiMed Advisors and Borealis Ventures. Bill Maris of Google Ventures will join Adimab's Board of Directors. The total amount of the financing was not disclosed.
Regenerative medicine researchers at UT Southwestern Medical Center developed an improved and simplified gene-editing technique using CRISPR/Cas9 tools to correct a common mutation that causes Duchenne muscular dystrophy.
Prostate tumors that carry a "signature" of four molecular markers have the potential to become dangerously metastatic if not treated aggressively, researchers at Dana-Farber Cancer Institute report in a study published online today by the journal Nature. The discovery lays the groundwork for the first gene-based test for determining whether a man's prostate cancer is likely to remain dormant within the prostate gland, or spread lethally to other parts of the body.
Kisspeptin neurons appear to play a role in hypogonadotropic anovulation caused by excessive levels of prolactin, research shows.
› Verified 4 days ago
Juan Toledo Diaz, MD Nephrology Medicare: Medicare Enrolled Practice Location: Hc 04 Box 30580, Hatillo, PR 00659 Phone: 787-226-5922 | |
Samuel Rivera, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: Policlinica Bayaney Carr 129 Km. 15.1, Barrio Bayaney, Hatillo, PR 00659 Phone: 787-898-7990 | |
Dr. Gabriel G Torres, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: Carretera 129 Km 15.0 Hatill P.r.00659, Bayaney Profesional Plaza, Hatillo, PR 00659 Phone: 787-898-2206 Fax: 787-898-2206 | |
Dr. Juan Jose Nieves-rivera, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: Pr-130 Km. 11.8, Bo. Campo Alegre, Hatillo, PR 00659 Phone: 787-898-8777 Fax: 787-933-8497 | |
Janice Mariel Cuevas Rivera, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: Parcelas Capaez Calle F, Casa 196 Bo. Capaez, Hatillo, PR 00659 Phone: 787-432-8329 | |
Dr. Luis F Sotomayor, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: Ave. Dr. Susoni, # 284 B, Hatillo, PR 00659 Phone: 787-898-3387 Fax: 787-898-3387 |